BYSI - BeyondSpring, Inc.
Earnings Results

BeyondSpring, Inc. ( $BYSI )

Recent earnings result


Events & Presentations

BeyondSpring Inc BYSI CEO Lan Huang on Q2 2020 Results

Supporting docs

  1. Listen to webcast

Top Stories (BYSI)

Events & Annual meetings

Title Date Webcast
BeyondSpring Inc BYSI CEO Lan Huang on Q2 2020 Results 9/5/2020 videos.earningsahead.com webcast
BeyondSpring Third-Quarter 2019 Financial Results and Operational Update Wednesday, Dec 18, 2019 at 8:00 AM EST
BeyondSpring Second-Quarter 2019 Financial Results and Operational Update Wednesday, Sep 18, 2019 at 8:00 AM EDT public.viavid.com webcast
BeyondSpring at H.C. Wainwright 21st Annual Global Investment Conference Tuesday, Sep 10, 2019 at 10:00 AM EDT wsw.com webcast
BeyondSpring at Jefferies 2019 Healthcare Conference Friday, Jun 07, 2019 at 9:00 AM EDT wsw.com webcast





BeyondSpring is a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. Its lead asset, immuno-oncology agent Plinabulin, is currently in multiple global registration studies, for the prevention of chemotherapy-induced neutropenia and as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC).


Videos about BeyondSpring, Inc.

Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading